American Journal of Transplantation: Volume 16, Number 5, May 2016

On the cover this month: The shortage of kidneys continues to drive clinicians to expand the criteria for donor organ suitability, including the use of organs that are blood group ABO‐incompatible (ABOi). This month, Axelrod et al ( page 1465) provide an in‐depth analysis of the cost and benefit of ABOi transplants in the United States, explicitly defining the incremental cost and decremental survival associated with this approach. Their thoughtful discussion, combined with an editorial by Held and McCormick ( page 1343), provides a broad perspective on this practice. Also, several articles appear analyzing the revised Banff 2013 criteria for antibody‐mediated rejection (ABMR; see minireview by Haas, page 1352, and article by De Serres et al, page 1516) and trials for the treatment of ABMR (see article by Viglietti et al on page 1596 and Montgomery's editorial on page 1350). Cover design by Ken North, North Design Group.